SKI Market

A+| A| A-|

Indian Indices

Sensex

75,035.26 -165.59
( -0.22%)

Global Indices

Nasdaq

49,407.34 -299.79
(-0.60%)

Dow Jones

7,377.26 -46.79
(-0.63%)

Hang Seng

59,717.33 -833.26
(-1.38%)

Nikkei 225

10,329.19 5.44
(0.05%)

Forex

USD-INR

96.22 0.33
(0.34%)

EUR-INR

111.98 0.52
(0.46%)

GBP-INR

128.69 0.96
(0.75%)

JPY-INR

0.61 0.00
(0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lypsa Gems & Jewellery Ltd

Industry : Diamond Cutting / Jewellery

BSE Code

ISIN Demat

Book Value()

534532

INE142K01011

5.6345815

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYPSAGEMS

14.77

EPS(TTM)

Face Value()

Div & Yield %

Back

mrf ltd

Balaxi Pharmaceuticals standalone net profit declines 12.07% in the December 2025 quarter

Jan 28,2026

Net profit of Balaxi Pharmaceuticals declined 12.07% to Rs 1.53 crore in the quarter ended December 2025 as against Rs 1.74 crore during the previous quarter ended December 2024. Sales rose 120.34% to Rs 24.59 crore in the quarter ended December 2025 as against Rs 11.16 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	24.59	11.16	120
OPM %	5.61	0.81	-
PBDT	2.27	2.44	-7
PBT	2.12	2.33	-9
NP	1.53	1.74	-12

75,035.26 -165.59 ( -0.22%)

49,407.34 -299.79 (-0.60%)

7,377.26 -46.79 (-0.63%)

59,717.33 -833.26 (-1.38%)

10,329.19 5.44 (0.05%)

96.22 0.33 (0.34%)

111.98 0.52 (0.46%)

128.69 0.96 (0.75%)

0.61 0.00 (0.28%)